Korro Bio
KRRO
41 hedge funds and large institutions have $1.67M invested in Korro Bio in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 11 reducing their positions, and 6 closing their positions.
1,000% more call options, than puts
Call options by funds: $11K | Put options by funds: $1K
0.01% less ownership
Funds ownership: 0.28% → 0.27% (-0.01%)
5% less funds holding
Funds holding: 43 → 41 (-2)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
34% less capital invested
Capital invested by funds: $2.52M → $1.67M (-$849K)
64% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 11
Top Buyers
| 1 |
Millennium Management
New York
|
+$13.2K |
| 2 |
WP
WealthSource Partners
San Luis Obispo,
California
|
+$9.02K |
| 3 |
Renaissance Technologies
New York
|
+$8.81K |
| 4 |
SG
StoneX Group
New York
|
+$5.63K |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$1.94K |
Top Sellers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$37K |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$34K |
| 3 |
Morgan Stanley
New York
|
-$32K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$31.6K |
| 5 |
BlackRock
New York
|
-$29K |
KRRO Hedge Fund Activity: Q2 2023 in Review
41 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Korro Bio (KRRO) for Q2 2023, worth a combined $1.67M — down 34% from $2.52M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of KRRO and 4 opened new positions — a net loss of 2 holders — while 11 trimmed existing stakes and 4 added.
The largest buyer was Millennium Management, adding an estimated $13.2K. The largest seller was Susquehanna International Group, cutting an estimated $37K.
- 41 institutional investors held Korro Bio (KRRO) as of Q2 2023, down from 43 in Q1 2023.
- Funds reported $1.67M of Korro Bio stock for Q2 2023, down 34% quarter-over-quarter.
- 4 funds opened new Korro Bio positions in Q2 2023 and 6 closed out, a net change of -2 holders.
- The largest Korro Bio buyer in Q2 2023 was Millennium Management, an estimated $13.2K added.
- The largest Korro Bio seller in Q2 2023 was Susquehanna International Group, an estimated $37K sold.
Based on aggregated 13F filings for Q2 2023.